Golimumab

Golimumab belongs to a class of biologic medications known as tissue necrosis factor alpha (TNF-α)-blockers. Excess amounts of TNF-α causes the immune system to attack healthy cells in the target area such as gastrointestinal (GI) tract or joints, resulting in inflammation. Golimumab binds to TNF-α, blocking its action to help improve symptoms.